Skip to main content
. 2020 Nov 10;11:583525. doi: 10.3389/fmicb.2020.583525

FIGURE 3.

FIGURE 3

Microbial biomarkers among healthy individuals (H) and NLCLC patients (before the first therapy T1 and before the tenth therapy T10). Significantly different abundant taxa as biomarkers using Kruskal–Wallis test (P < 0.05) with LDA score > 2.0. based on LEfSe analysis.